-
bone marrow transplantation. We are looking for a highly motivated candidate with a PhD degree interested in using microbiological methods with the aim of developing novel strategies to improve bone
-
on drug development, uncovering basic mechanisms, and identifying novel therapeutic targets in leukemogenesis and solid tumors. Specifically, we study genetic and epigenetic biomarkers with prognostic value
-
are looking for a highly motivated candidate with a PhD and/or MD degree interested in combining novel rational and combinatorial synthetic biology approaches with computational methods to develop strategies
-
/surgeons to plan, design, and execute computational analyses. Advance the integration of multi-omics and clinical datasets to uncover mechanisms of tumor evolution, therapeutic resistance, and potential
-
co-receptors. · Program our HTS robotics platform to interrogate small-molecule libraries; triage hits, coordinate SAR follow-up, and shepherd hit-to-lead evolutions. · Express and
-
discovery approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer
-
) development of small molecule drugs and PROTAC-drug conjugates. The Li group conducts the most forefront science and is highly productive with publications in high-impact journals in the past five years, Nature
-
priority. For more information about Dr. Vu Ngo’s research, please visit here . As a successful candidate, you will: Plan, design, and execute experiments independently and in collaboration with lab members
-
for Cancer and Aging is led by Dr. William Dale and is housed within the Supportive Care Research and Training Division. Our research program focuses on studies related to cancer and aging, exploring
-
are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis, and predictive